Chronic schistosomiasis
Schisto · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Chronic schistosomiasis results from egg-induced granulomatous inflammation: hepatosplenic/intestinal disease (S. mansoni/japonicum) or urogenital disease with bladder fibrosis and cancer risk (S. haematobium). Praziquantel treats active infection; complications need organ-specific care.
Red flags
- Variceal haemorrhage (hepatosplenic disease)
- Neuroschistosomiasis (myelopathy, seizures)
- Obstructive uropathy/renal failure
- Haematuria with suspected bladder carcinoma
- Pulmonary hypertension
Assessment
Differential diagnosis
- Other causes of portal hypertension (cirrhosis)
- Bladder malignancy/other haematuria causes
- Chronic hepatitis
- Other intestinal parasitosis
- Ectopic disease (neuroschistosomiasis, pulmonary hypertension)
Investigations
- Stool (S. mansoni/japonicum) or urine (S. haematobium) microscopy for eggs
- Schistosome serology (useful in travellers/light infection)
- Ultrasound (liver/periportal fibrosis; bladder/urinary tract)
- FBC (eosinophilia), liver and renal function
- Urinalysis for haematuria (urogenital disease)
- Endoscopy for varices in hepatosplenic disease
Management
- Confirm species and infection with egg microscopy and/or serology
- Assess organ involvement with ultrasound and relevant investigations
- Treat active infection with praziquantel
- Repeat/retreat as egg excretion and maturity dictate (praziquantel less active against immature worms)
- Manage portal hypertension and varices in hepatosplenic disease
- Manage urinary tract obstruction/fibrosis and screen for bladder cancer in urogenital disease
- Consider corticosteroids for acute severe/ectopic inflammatory disease (e.g. neuroschistosomiasis)
- Treat ectopic complications (spinal cord, pulmonary hypertension) with specialist input
- Follow up with repeat parasitology to confirm cure
- Counsel on reinfection risk and freshwater avoidance
- Address co-infections (e.g. hepatitis) affecting the liver
- Long-term surveillance for complications
Drugs & doses
Praziquantel 40 mg/kg PO (single dose or divided) for S. mansoni/haematobium
Praziquantel 60 mg/kg PO (divided) for S. japonicum/mekongi
Corticosteroids (e.g. prednisolone) adjunct for neuroschistosomiasis/severe acute inflammation
Repeat praziquantel at 4-6 weeks to target maturing worms in travellers
Disposition
Outpatient tropical medicine/ID; admit for complications (variceal bleed, neuroschistosomiasis); long-term surveillance.
Complications & pitfalls
- Periportal (Symmers) fibrosis and portal hypertension
- Bladder fibrosis, obstruction and squamous cell carcinoma
- Neuroschistosomiasis
- Pulmonary hypertension
- Chronic anaemia and growth impairment
Exam pearls
- Praziquantel is poorly active against immature worms - repeat dosing in recent/travel infection
- Urogenital schistosomiasis is a risk factor for bladder squamous cell carcinoma
- Serology aids diagnosis in light infections and returning travellers
- Egg-induced fibrosis may persist despite cure of active infection
- Consider neuroschistosomiasis in unexplained myelopathy after freshwater exposure
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.